ResMed engages in ongoing clinical research that aligns with our mission of advancing innovative technologies in sleep and respiratory medicine. We support both independent and ResMed-sponsored clinical research that provides deeper insight for the diagnosis, treatment and management of sleep-disordered breathing (SDB), chronic obtrusive pulmonary disease (COPD) and other chronic diseases.

  • Investigator-initiated research
    • ResMed believes in the need to support ethical, independent clinical research, conducted by qualified third-party investigators.
    • Learn how to submit a proposal
  • ResMed-sponsored research
    • The HOT-HMV study
      • Result: 51% decrease in risk of hospital readmission or death in hypercapnia COPD patients treated with home non-invasive ventilation and oxygen therapy
  • Farrell favorites
    • Dr. Peter Farrell, ResMed Founder and Chairman, identifies key research findings that are shaping the field of sleep medicine.